236 related articles for article (PubMed ID: 33481833)
1. Gut microbiome dysbiosis and correlation with blood biomarkers in active-tuberculosis in endemic setting.
Khaliq A; Ravindran R; Afzal S; Jena PK; Akhtar MW; Ambreen A; Wan YY; Malik KA; Irfan M; Khan IH
PLoS One; 2021; 16(1):e0245534. PubMed ID: 33481833
[TBL] [Abstract][Full Text] [Related]
2. The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
Eribo OA; du Plessis N; Ozturk M; Guler R; Walzl G; Chegou NN
Cell Mol Life Sci; 2020 Apr; 77(8):1497-1509. PubMed ID: 31729564
[TBL] [Abstract][Full Text] [Related]
3. Gut bacterial and fungal dysbiosis in tuberculosis patients.
Han M; Wang X; Zhang J; Su L; Ishaq HM; Li D; Cui J; Zhao H; Yang F
BMC Microbiol; 2024 Apr; 24(1):141. PubMed ID: 38658829
[TBL] [Abstract][Full Text] [Related]
4. Systemic proinflammation after Mycobacterium tuberculosis infection was correlated to the gut microbiome in HIV-uninfected humans.
Huang SF; Yang YY; Chou KT; Fung CP; Wang FD; Su WJ
Eur J Clin Invest; 2019 May; 49(5):e13068. PubMed ID: 30620398
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota associated with pulmonary tuberculosis and dysbiosis caused by anti-tuberculosis drugs.
Hu Y; Yang Q; Liu B; Dong J; Sun L; Zhu Y; Su H; Yang J; Yang F; Chen X; Jin Q
J Infect; 2019 Apr; 78(4):317-322. PubMed ID: 30107196
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiome contributes to impairment of immunity in pulmonary tuberculosis patients by alteration of butyrate and propionate producers.
Maji A; Misra R; Dhakan DB; Gupta V; Mahato NK; Saxena R; Mittal P; Thukral N; Sharma E; Singh A; Virmani R; Gaur M; Singh H; Hasija Y; Arora G; Agrawal A; Chaudhry A; Khurana JP; Sharma VK; Lal R; Singh Y
Environ Microbiol; 2018 Jan; 20(1):402-419. PubMed ID: 29322681
[TBL] [Abstract][Full Text] [Related]
7. Differences in IgG responses against infection phase related Mycobacterium tuberculosis (Mtb) specific antigens in individuals exposed or not to Mtb correlate with control of TB infection and progression.
Coppola M; Arroyo L; van Meijgaarden KE; Franken KL; Geluk A; Barrera LF; Ottenhoff THM
Tuberculosis (Edinb); 2017 Sep; 106():25-32. PubMed ID: 28802401
[TBL] [Abstract][Full Text] [Related]
8. The host microbiome and impact of tuberculosis chemotherapy.
O'Toole RF; Gautam SS
Tuberculosis (Edinb); 2018 Dec; 113():26-29. PubMed ID: 30514510
[TBL] [Abstract][Full Text] [Related]
9. The gut microbiota mediates protective immunity against tuberculosis
Yang F; Yang Y; Chen L; Zhang Z; Liu L; Zhang C; Mai Q; Chen Y; Chen Z; Lin T; Chen L; Guo H; Zhou L; Shen H; Chen X; Liu L; Zhang G; Liao H; Zeng L; Zeng G
Gut Microbes; 2022; 14(1):2029997. PubMed ID: 35343370
[TBL] [Abstract][Full Text] [Related]
10. The Gut Microbiome Signatures Discriminate Healthy From Pulmonary Tuberculosis Patients.
Hu Y; Feng Y; Wu J; Liu F; Zhang Z; Hao Y; Liang S; Li B; Li J; Lv N; Xu Y; Zhu B; Sun Z
Front Cell Infect Microbiol; 2019; 9():90. PubMed ID: 31001490
[TBL] [Abstract][Full Text] [Related]
11. Impact of tuberculosis disease on human gut microbiota: a systematic review.
Baral T; Kurian SJ; Thomas L; Udyavara Kudru C; Mukhopadhyay C; Saravu K; Manu MK; Singh J; Munisamy M; Kumar A; Khandelwal B; Rao M; Sekhar Miraj S
Expert Rev Anti Infect Ther; 2023 Feb; 21(2):175-188. PubMed ID: 36564016
[TBL] [Abstract][Full Text] [Related]
12. Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques.
Namasivayam S; Kauffman KD; McCulloch JA; Yuan W; Thovarai V; Mittereder LR; Trinchieri G; Barber DL; Sher A
mBio; 2019 Jun; 10(3):. PubMed ID: 31164469
[TBL] [Abstract][Full Text] [Related]
13. Microbiome-immune interactions in tuberculosis.
Mori G; Morrison M; Blumenthal A
PLoS Pathog; 2021 Apr; 17(4):e1009377. PubMed ID: 33857251
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiome, T cell subsets, and cytokine analysis identify differential biomarkers in tuberculosis.
Chai Y; Liu X; Bai G; Zhou N; Liu D; Zhang X; Li M; Li K; Lei H
Front Immunol; 2024; 15():1323723. PubMed ID: 38650928
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiome dysbiosis alleviates the progression of osteoarthritis in mice.
Guan Z; Jia J; Zhang C; Sun T; Zhang W; Yuan W; Leng H; Song C
Clin Sci (Lond); 2020 Dec; 134(23):3159-3174. PubMed ID: 33215637
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota dysbiosis in a cohort of patients with psoriasis.
Hidalgo-Cantabrana C; Gómez J; Delgado S; Requena-López S; Queiro-Silva R; Margolles A; Coto E; Sánchez B; Coto-Segura P
Br J Dermatol; 2019 Dec; 181(6):1287-1295. PubMed ID: 30920647
[TBL] [Abstract][Full Text] [Related]
17. Full-length 16S rDNA sequencing based on Oxford Nanopore Technologies revealed the association between gut-pharyngeal microbiota and tuberculosis in cynomolgus macaques.
Sawaswong V; Chanchaem P; Klomkliew P; Rotcheewaphan S; Meesawat S; Kemthong T; Kaewparuehaschai M; Noradechanon K; Ekatat M; Kanitpun R; Srilohasin P; Warit S; Chaiprasert A; Malaivijitnond S; Payungporn S
Sci Rep; 2024 Feb; 14(1):3404. PubMed ID: 38337025
[TBL] [Abstract][Full Text] [Related]
18. Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in mice.
Negi S; Pahari S; Bashir H; Agrewala JN
Eur J Immunol; 2020 Dec; 50(12):1976-1987. PubMed ID: 32673409
[TBL] [Abstract][Full Text] [Related]
19. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
20. A murine model of tuberculosis/type 2 diabetes comorbidity for investigating the microbiome, metabolome and associated immune parameters.
Sathkumara HD; Eaton JL; Field MA; Govan BL; Ketheesan N; Kupz A
Animal Model Exp Med; 2021 Jun; 4(2):181-188. PubMed ID: 34179725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
